Filtros : "ADJUVANTES IMUNOLÓGICOS" "IQ005" Removidos: "Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School 8 of Medicine, Baltimore, MD, USA" "GOMES, CRISTINA DE OLIVEIRA MASSOCO SALLES" "RIVAS, ANA CAROLINA APARECIDA" "Financiamento FCT" Limpar

Filtros



Limitar por data


  • Fonte: Biomimetics. Unidade: IQ

    Assuntos: NANOTECNOLOGIA, VACINAS, LIPÍDEOS, NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMONA-RIBEIRO, Ana Maria. Supramolecular nanostructures for vaccines. Biomimetics, v. 7, p. 1-21 art. 6, 2022Tradução . . Disponível em: https://doi.org/10.3390/biomimetics7010006. Acesso em: 12 jul. 2024.
    • APA

      Carmona-Ribeiro, A. M. (2022). Supramolecular nanostructures for vaccines. Biomimetics, 7, 1-21 art. 6. doi:10.3390/biomimetics7010006
    • NLM

      Carmona-Ribeiro AM. Supramolecular nanostructures for vaccines [Internet]. Biomimetics. 2022 ; 7 1-21 art. 6.[citado 2024 jul. 12 ] Available from: https://doi.org/10.3390/biomimetics7010006
    • Vancouver

      Carmona-Ribeiro AM. Supramolecular nanostructures for vaccines [Internet]. Biomimetics. 2022 ; 7 1-21 art. 6.[citado 2024 jul. 12 ] Available from: https://doi.org/10.3390/biomimetics7010006
  • Fonte: Maccine Design: Methods and Protocols, Resources for Vaccine Development. Unidades: IQ, FCF

    Assuntos: VACINAS, NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMONA-RIBEIRO, Ana Maria e MATHIAZZI, Beatriz Ideriha e PÉREZ-BETANCOURT, Yunys. Cationic nanostructures as adjuvants for vaccines. Maccine Design: Methods and Protocols, Resources for Vaccine Development. Tradução . New York: Humana, 2022. . . Acesso em: 12 jul. 2024.
    • APA

      Carmona-Ribeiro, A. M., Mathiazzi, B. I., & Pérez-Betancourt, Y. (2022). Cationic nanostructures as adjuvants for vaccines. In Maccine Design: Methods and Protocols, Resources for Vaccine Development. New York: Humana.
    • NLM

      Carmona-Ribeiro AM, Mathiazzi BI, Pérez-Betancourt Y. Cationic nanostructures as adjuvants for vaccines. In: Maccine Design: Methods and Protocols, Resources for Vaccine Development. New York: Humana; 2022. [citado 2024 jul. 12 ]
    • Vancouver

      Carmona-Ribeiro AM, Mathiazzi BI, Pérez-Betancourt Y. Cationic nanostructures as adjuvants for vaccines. In: Maccine Design: Methods and Protocols, Resources for Vaccine Development. New York: Humana; 2022. [citado 2024 jul. 12 ]
  • Fonte: Vaccines. Unidade: IQ

    Assuntos: NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PÉREZ-BETANCOURT, Yunys et al. Simple nanoparticles from the assembly of cationic polymer and antigen as immunoadjuvants. Vaccines, v. 8, n. 1, p. 1-13 art. 105, 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8010105. Acesso em: 12 jul. 2024.
    • APA

      Pérez-Betancourt, Y., Távora, B. de C. L. F., Colombini, M., Faquim-Mauro, E. L., & Carmona-Ribeiro, A. M. (2020). Simple nanoparticles from the assembly of cationic polymer and antigen as immunoadjuvants. Vaccines, 8( 1), 1-13 art. 105. doi:10.3390/vaccines8010105
    • NLM

      Pérez-Betancourt Y, Távora B de CLF, Colombini M, Faquim-Mauro EL, Carmona-Ribeiro AM. Simple nanoparticles from the assembly of cationic polymer and antigen as immunoadjuvants [Internet]. Vaccines. 2020 ; 8( 1): 1-13 art. 105.[citado 2024 jul. 12 ] Available from: https://doi.org/10.3390/vaccines8010105
    • Vancouver

      Pérez-Betancourt Y, Távora B de CLF, Colombini M, Faquim-Mauro EL, Carmona-Ribeiro AM. Simple nanoparticles from the assembly of cationic polymer and antigen as immunoadjuvants [Internet]. Vaccines. 2020 ; 8( 1): 1-13 art. 105.[citado 2024 jul. 12 ] Available from: https://doi.org/10.3390/vaccines8010105
  • Fonte: Surfactants and Detergents. Unidade: IQ

    Assuntos: NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMONA-RIBEIRO, Ana Maria. Biomimetic nanomaterials from the assembly of polymers, lipids, and surfactants. Surfactants and Detergents. Tradução . London: IntechOpen, 2019. . Disponível em: https://doi.org/10.5772/intechopen.84618. Acesso em: 12 jul. 2024.
    • APA

      Carmona-Ribeiro, A. M. (2019). Biomimetic nanomaterials from the assembly of polymers, lipids, and surfactants. In Surfactants and Detergents. London: IntechOpen. doi:10.5772/intechopen.84618
    • NLM

      Carmona-Ribeiro AM. Biomimetic nanomaterials from the assembly of polymers, lipids, and surfactants [Internet]. In: Surfactants and Detergents. London: IntechOpen; 2019. [citado 2024 jul. 12 ] Available from: https://doi.org/10.5772/intechopen.84618
    • Vancouver

      Carmona-Ribeiro AM. Biomimetic nanomaterials from the assembly of polymers, lipids, and surfactants [Internet]. In: Surfactants and Detergents. London: IntechOpen; 2019. [citado 2024 jul. 12 ] Available from: https://doi.org/10.5772/intechopen.84618
  • Fonte: Stem Cells Translational Medicine. Unidade: IQ

    Assuntos: ADJUVANTES IMUNOLÓGICOS, CÉLULAS-TRONCO, LINFÓCITOS T

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIMENO, Maria L et al. Pluripotent Nontumorigenic Adipose Tissue Derived Muse Cells Have Immunomodulatory Capacity Mediated by Transforming Growth Factor β1. Stem Cells Translational Medicine, v. 6, n. 1, p. 161-173, 2017Tradução . . Disponível em: https://doi.org/10.5966/sctm.2016-0014. Acesso em: 12 jul. 2024.
    • APA

      Gimeno, M. L., Fuertes, F., Tabarrozzi, A. E. B., Attorressi, A. I., Cucchiani, R., Corrales, L., et al. (2017). Pluripotent Nontumorigenic Adipose Tissue Derived Muse Cells Have Immunomodulatory Capacity Mediated by Transforming Growth Factor β1. Stem Cells Translational Medicine, 6( 1), 161-173. doi:10.5966/sctm.2016-0014
    • NLM

      Gimeno ML, Fuertes F, Tabarrozzi AEB, Attorressi AI, Cucchiani R, Corrales L, Oliveira TC, Sogayar MC, Labriola L, Dewey RA, Perone MJ. Pluripotent Nontumorigenic Adipose Tissue Derived Muse Cells Have Immunomodulatory Capacity Mediated by Transforming Growth Factor β1 [Internet]. Stem Cells Translational Medicine. 2017 ; 6( 1): 161-173.[citado 2024 jul. 12 ] Available from: https://doi.org/10.5966/sctm.2016-0014
    • Vancouver

      Gimeno ML, Fuertes F, Tabarrozzi AEB, Attorressi AI, Cucchiani R, Corrales L, Oliveira TC, Sogayar MC, Labriola L, Dewey RA, Perone MJ. Pluripotent Nontumorigenic Adipose Tissue Derived Muse Cells Have Immunomodulatory Capacity Mediated by Transforming Growth Factor β1 [Internet]. Stem Cells Translational Medicine. 2017 ; 6( 1): 161-173.[citado 2024 jul. 12 ] Available from: https://doi.org/10.5966/sctm.2016-0014
  • Fonte: Purinergic Signalling. Nome do evento: International Congress on Purinergic Signaling in South America. Unidade: IQ

    Assuntos: CÉLULAS-TRONCO, ADJUVANTES IMUNOLÓGICOS

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BREZNIK, B et al. Mesenchymal stem cells up-regulate the expression of proteolytic enzymes in glioblastoma as part of their immunomodulatory-like response. Purinergic Signalling. Dordrecht: Springer. . Acesso em: 12 jul. 2024. , 2016
    • APA

      Breznik, B., Motaln, H., Golob, M., Ulrich, H., & Turnŝek, T. L. (2016). Mesenchymal stem cells up-regulate the expression of proteolytic enzymes in glioblastoma as part of their immunomodulatory-like response. Purinergic Signalling. Dordrecht: Springer.
    • NLM

      Breznik B, Motaln H, Golob M, Ulrich H, Turnŝek TL. Mesenchymal stem cells up-regulate the expression of proteolytic enzymes in glioblastoma as part of their immunomodulatory-like response. Purinergic Signalling. 2016 ; 12( 49 p. 400-401):[citado 2024 jul. 12 ]
    • Vancouver

      Breznik B, Motaln H, Golob M, Ulrich H, Turnŝek TL. Mesenchymal stem cells up-regulate the expression of proteolytic enzymes in glioblastoma as part of their immunomodulatory-like response. Purinergic Signalling. 2016 ; 12( 49 p. 400-401):[citado 2024 jul. 12 ]
  • Fonte: Stem Cell Reviews and Reports. Unidade: IQ

    Assuntos: ADJUVANTES IMUNOLÓGICOS, CÉLULAS-TRONCO, CITOCINAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning et al. Immunomodulation in stem cell differentiation into neurons and brain repair. Stem Cell Reviews and Reports, v. 11, n. 3, p. 474-486, 2015Tradução . . Disponível em: https://doi.org/10.1007/s12015-014-9556-6. Acesso em: 12 jul. 2024.
    • APA

      Ulrich, H., Nascimento, I. C. do, Bocsi, J., & Tárnok, A. (2015). Immunomodulation in stem cell differentiation into neurons and brain repair. Stem Cell Reviews and Reports, 11( 3), 474-486. doi:10.1007/s12015-014-9556-6
    • NLM

      Ulrich H, Nascimento IC do, Bocsi J, Tárnok A. Immunomodulation in stem cell differentiation into neurons and brain repair [Internet]. Stem Cell Reviews and Reports. 2015 ; 11( 3): 474-486.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s12015-014-9556-6
    • Vancouver

      Ulrich H, Nascimento IC do, Bocsi J, Tárnok A. Immunomodulation in stem cell differentiation into neurons and brain repair [Internet]. Stem Cell Reviews and Reports. 2015 ; 11( 3): 474-486.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s12015-014-9556-6
  • Fonte: Journal of Controlled Release. Unidade: IQ

    Assuntos: OLIGONUCLEOTÍDEOS, ADJUVANTES IMUNOLÓGICOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROZENFRELD, Julio Henrique Kravcuks et al. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo. Journal of Controlled Release, v. 160, n. 2, p. 367-373, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2011.10.017. Acesso em: 12 jul. 2024.
    • APA

      Rozenfreld, J. H. K., Silva, S. R., Ranéia, P. A., Faquim-Mauro, E., & Carmona-Ribeiro, A. M. (2012). Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo. Journal of Controlled Release, 160( 2), 367-373. doi:10.1016/j.jconrel.2011.10.017
    • NLM

      Rozenfreld JHK, Silva SR, Ranéia PA, Faquim-Mauro E, Carmona-Ribeiro AM. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo [Internet]. Journal of Controlled Release. 2012 ; 160( 2): 367-373.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1016/j.jconrel.2011.10.017
    • Vancouver

      Rozenfreld JHK, Silva SR, Ranéia PA, Faquim-Mauro E, Carmona-Ribeiro AM. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo [Internet]. Journal of Controlled Release. 2012 ; 160( 2): 367-373.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1016/j.jconrel.2011.10.017

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024